Welcome to LookChem.com Sign In|Join Free
  • or
nobilamide B is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1310050-75-9

Post Buying Request

1310050-75-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1310050-75-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1310050-75-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,0,0,5 and 0 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1310050-75:
(9*1)+(8*3)+(7*1)+(6*0)+(5*0)+(4*5)+(3*0)+(2*7)+(1*5)=79
79 % 10 = 9
So 1310050-75-9 is a valid CAS Registry Number.

1310050-75-9Relevant academic research and scientific papers

On the inhibition of capsaicin response in dorsal root ganglion neurons by nobilamide B and analogues: a structure-activity relationship study

Belleza, Oliver John V.,Tun, Jortan O.,Concepcion, Gisela P.,Villaraza, Aaron Joseph L.

, p. 1673 - 1678 (2018/10/26)

Nobilamide B, a TRPV1 antagonist, and a series of Ala-substituted analogues were synthesized and their neuroactivity was assessed in a primary culture of dorsal root ganglion (DRG) neurons. Analogues 4, 6, and 7 showed comparable activity, affecting capsaicin response in neurons, in contrast to 2, 3, and 5 which showed minimal blocking. Compounds 2, 3, and 5 correspond to analogues in which d-Phe, d-Leu and d-allo-Thr have been substituted with Ala, respectively. The observed loss of bioactivity in these three analogues highlights the importance of d amino acids in the primary structure of nobilamide B.

Total syntheses of nobilamides B and D: Application of traceless Staudinger ligation

Yamashita, Tomoya,Matoba, Hiroaki,Kuranaga, Takefumi,Inoue, Masayuki

, p. 7746 - 7752 (2014/12/10)

Nobilamide B is a long-acting antagonist of transient receptor potential vanilloid-1 (TRPV1), and is expected to show therapeutic potential for treatment of pain. This linear heptapeptide possesses a Z-didehydroaminobutanoic acid moiety at the C-terminus. Stereoselective construction of the didehydroamino acid moiety was successfully achieved by application of the traceless Staudinger ligation. The combination of solid-phase peptide synthesis and the Staudinger ligation allowed rapid access to not only nobilamide B, but also its macrocyclic analogue nobilamide D.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1310050-75-9